Cheng, Xiao-Ping
Wu, Yu-Qiong
Luo, Kai-Liang
Wu, Di
Lv, Lan
Xie, Li-Li
Zhan, Li-Qiong
Zhou, Yue-Zhu
Ni, Jun
Chen, Xin-Yuan
Funding for this research was provided by:
the Startup Fund for Scientific Research of Fujian Medical University (2023QH1112)
the National Natural Science Foundation of China (61773124)
the National Natural Science Foundation of China (82402952)
Article History
Received: 18 July 2025
Accepted: 11 March 2026
First Online: 17 March 2026
Declarations
:
: The study was approved by the Ethics Committee of the First Affiliated Hospital of Fujian Medical University (Ethics Approval No. [2021]217) and the trial was retrospectively registered in the Chinese Clinical Trial Registry (Registration No.: ChiCTR2300070580). Additionally, this study involved human subjects and/or human data and adhered to the Declaration of Helsinki. Included patients received written as well as verbal information about the study protocol and signed an informed consent form before initiating the study.
: Not applicable.
: The authors declare no competing interests.